在患有末期或慢性病的患者中,对心房的早期节律控制
Dong-Seon Kang1, Daehoon Kim2, Eunsun Jang2
1Department of Cardiology, Kangdong Sacred Heart Hospital, Seoul, Republic of Korea.
Mayo Clinic proceedings
|March 9, 2025
概括
患有慢性病 (CKD) 的心房动 (AF) 患者的早期节律控制 (ERC) 在CKD 3-4阶段显示出好处,但不是末期病 (ESKD). 考虑到功能,定制的AF治疗策略至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在慢性病 (CKD) 患者中,心房动 (AF) 是常见的.
- 早期节律控制 (ERC) 旨在维持AF患者的鼻节律.
- 在慢性病患者,特别是末期病患者 (ESKD) 中,ERC的风险-益处概况尚未明确.
研究的目的:
- 研究早期节律控制 (ERC) 与心房 (AF) 和慢性病 (CKD) 的不同阶段患者的节律控制的益处和风险.
- 在CKD和ESKD人群中比较ERC和速率控制策略之间的心血管结果和安全事件.
主要方法:
- 一项基于人口的队列研究包括5224名AF患者 (平均年龄70岁) 患有ESKD (n=1660) 和CKD阶段3-4 (n=3564).
- 患者在2005年至2015年期间接受了ERC或速率控制.
- 主要结局包括心血管死亡,缺血性中风,心力衰竭住院治疗和急性心肌梗塞.
主要成果:
- 在CKD3-4期患者中,ERC与初级结局的风险降低有关,而没有增加安全风险.
- 在ESKD患者中,ERC在初级结果中没有显著差异,但与复合安全结果的增加有关.
- 对ERC的坚持不佳,ESKD的65.0%和CKD阶段3-4的57.3%的患者在随访期间未能保持ERC.
结论:
- 早期节律控制在ESKD患者中具有适度的风险-益处概况,与CKD 3-4期患者相比.
- 对ERC的不良遵守会对其有效性产生重大影响,特别是在ESKD.
- 根据患者的功能,AF治疗策略应该是个性化的.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
Disturbances in Heart Rhythm
842
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
842
Factors Affecting Renal Clearance: Renal Impairment
47
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
47
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
879
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
879


